CALD1_HUMAN - dbPTM
CALD1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CALD1_HUMAN
UniProt AC Q05682
Protein Name Caldesmon
Gene Name CALD1
Organism Homo sapiens (Human).
Sequence Length 793
Subcellular Localization Cytoplasm, cytoskeleton. Cytoplasm, myofibril. On thin filaments in smooth muscle and on stress fibers in fibroblasts (nonmuscle)..
Protein Description Actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity)..
Protein Sequence MDDFERRRELRRQKREEMRLEAERIAYQRNDDDEEEAARERRRRARQERLRQKQEEESLGQVTDQVEVNAQNSVPDEEAKTTTTNTQVEGDDEAAFLERLARREERRQKRLQEALERQKEFDPTITDASLSLPSRRMQNDTAENETTEKEEKSESRQERYEIEETETVTKSYQKNDWRDAEENKKEDKEKEEEEEEKPKRGSIGENQVEVMVEEKTTESQEETVVMSLKNGQISSEEPKQEEEREQGSDEISHHEKMEEEDKERAEAERARLEAEERERIKAEQDKKIADERARIEAEEKAAAQERERREAEERERMREEEKRAAEERQRIKEEEKRAAEERQRIKEEEKRAAEERQRIKEEEKRAAEERQRARAEEEEKAKVEEQKRNKQLEEKKHAMQETKIKGEKVEQKIEGKWVNEKKAQEDKLQTAVLKKQGEEKGTKVQAKREKLQEDKPTFKKEEIKDEKIKKDKEPKEEVKSFMDRKKGFTEVKSQNGEFMTHKLKHTENTFSRPGGRASVDTKEAEGAPQVEAGKRLEELRRRRGETESEEFEKLKQKQQEAALELEELKKKREERRKVLEEEEQRRKQEEADRKLREEEEKRRLKEEIERRRAEAAEKRQKMPEDGLSDDKKPFKCFTPKGSSLKIEERAEFLNKSVQKSSGVKSTHQAAIVSKIDSRLEQYTSAIEGTKSAKPTKPAASDLPVPAEGVRNIKSMWEKGNVFSSPTAAGTPNKETAGLKVGVSSRINEWLTKTPDGNKSPAPKPSDLRPGDVSSKRNLWEKQSVDKVTSPTKV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Sulfoxidation-------MDDFERRR
-------CCHHHHHH
11.4228183972
5 (in isoform 3)Phosphorylation-52.8823663014
5 (in isoform 5)Phosphorylation-52.8823663014
7 (in isoform 3)Phosphorylation-29.2722617229
7 (in isoform 5)Phosphorylation-29.2722617229
12 (in isoform 3)Phosphorylation-60.0230266825
12 (in isoform 5)Phosphorylation-60.0230266825
17 (in isoform 3)Phosphorylation-33.3730266825
17 (in isoform 5)Phosphorylation-33.3730266825
21 (in isoform 3)Phosphorylation-37.8130266825
21 (in isoform 5)Phosphorylation-37.8130266825
27PhosphorylationLEAERIAYQRNDDDE
HHHHHHHHHCCCCHH
12.9722817900
53AcetylationRQERLRQKQEEESLG
HHHHHHHHHHHHHHC
53.9226051181
58PhosphorylationRQKQEEESLGQVTDQ
HHHHHHHHHCCCCCC
40.8726657352
63PhosphorylationEESLGQVTDQVEVNA
HHHHCCCCCCCHHCC
16.9026657352
73PhosphorylationVEVNAQNSVPDEEAK
CHHCCCCCCCCHHHC
23.9724972180
81PhosphorylationVPDEEAKTTTTNTQV
CCCHHHCCCCCCCEE
36.1027251275
82PhosphorylationPDEEAKTTTTNTQVE
CCHHHCCCCCCCEEC
30.8027251275
83PhosphorylationDEEAKTTTTNTQVEG
CHHHCCCCCCCEECC
24.2330242111
84PhosphorylationEEAKTTTTNTQVEGD
HHHCCCCCCCEECCC
33.8929970186
86PhosphorylationAKTTTTNTQVEGDDE
HCCCCCCCEECCCHH
31.7226657352
119UbiquitinationQEALERQKEFDPTIT
HHHHHHHHHHCCCHH
67.57-
124PhosphorylationRQKEFDPTITDASLS
HHHHHCCCHHHHHHC
38.0529255136
126PhosphorylationKEFDPTITDASLSLP
HHHCCCHHHHHHCCC
28.1723403867
129PhosphorylationDPTITDASLSLPSRR
CCCHHHHHHCCCCHH
22.6930266825
131PhosphorylationTITDASLSLPSRRMQ
CHHHHHHCCCCHHHC
35.4230266825
134PhosphorylationDASLSLPSRRMQNDT
HHHHCCCCHHHCCCC
37.5030266825
137SulfoxidationLSLPSRRMQNDTAEN
HCCCCHHHCCCCCCC
4.1930846556
141PhosphorylationSRRMQNDTAENETTE
CHHHCCCCCCCCCCH
43.3421712546
146PhosphorylationNDTAENETTEKEEKS
CCCCCCCCCHHHHHH
52.4121601212
147PhosphorylationDTAENETTEKEEKSE
CCCCCCCCHHHHHHH
38.5921601212
149AcetylationAENETTEKEEKSESR
CCCCCCHHHHHHHHH
69.9126051181
152AcetylationETTEKEEKSESRQER
CCCHHHHHHHHHHHH
61.6926051181
153PhosphorylationTTEKEEKSESRQERY
CCHHHHHHHHHHHHH
44.0530242111
155PhosphorylationEKEEKSESRQERYEI
HHHHHHHHHHHHHHE
46.4824719451
160PhosphorylationSESRQERYEIEETET
HHHHHHHHHEEEHHH
22.1024927040
165PhosphorylationERYEIEETETVTKSY
HHHHEEEHHHHCHHH
24.9426356563
167PhosphorylationYEIEETETVTKSYQK
HHEEEHHHHCHHHHC
40.6821406692
169PhosphorylationIEETETVTKSYQKND
EEEHHHHCHHHHCCC
22.9926657352
170UbiquitinationEETETVTKSYQKNDW
EEHHHHCHHHHCCCC
42.71-
171PhosphorylationETETVTKSYQKNDWR
EHHHHCHHHHCCCCC
24.3528857561
172PhosphorylationTETVTKSYQKNDWRD
HHHHCHHHHCCCCCC
25.68-
174AcetylationTVTKSYQKNDWRDAE
HHCHHHHCCCCCCHH
48.9523236377
174UbiquitinationTVTKSYQKNDWRDAE
HHCHHHHCCCCCCHH
48.95-
196 (in isoform 3)Phosphorylation-77.3225159151
196 (in isoform 5)Phosphorylation-77.3222167270
197SumoylationKEEEEEEKPKRGSIG
HHHHHHHCCCCCCCC
60.15-
197SumoylationKEEEEEEKPKRGSIG
HHHHHHHCCCCCCCC
60.15-
202PhosphorylationEEKPKRGSIGENQVE
HHCCCCCCCCCCEEE
31.3029255136
202 (in isoform 2)Phosphorylation-31.3025159151
202 (in isoform 4)Phosphorylation-31.3022167270
202 (in isoform 6)Phosphorylation-31.3025159151
216PhosphorylationEVMVEEKTTESQEET
EEEEEECCCCCCHHE
38.7923312004
217PhosphorylationVMVEEKTTESQEETV
EEEEECCCCCCHHEE
44.7126657352
219PhosphorylationVEEKTTESQEETVVM
EEECCCCCCHHEEEE
40.5826657352
223PhosphorylationTTESQEETVVMSLKN
CCCCCHHEEEEEECC
20.0423312004
227PhosphorylationQEETVVMSLKNGQIS
CHHEEEEEECCCCCC
25.2827499020
235PhosphorylationLKNGQISSEEPKQEE
ECCCCCCCCCHHHHH
47.8326657352
248PhosphorylationEEEREQGSDEISHHE
HHHHHHCCHHCHHHH
31.5926657352
252PhosphorylationEQGSDEISHHEKMEE
HHCCHHCHHHHHHHH
19.4228509920
402PhosphorylationKKHAMQETKIKGEKV
HHHHHHHHHHCCHHH
22.6020860994
427AcetylationEKKAQEDKLQTAVLK
HHHHHHHHHHHHHHH
41.5611791317
427 (in isoform 6)Phosphorylation-41.5620166139
431 (in isoform 6)Phosphorylation-7.5321712546
459SumoylationQEDKPTFKKEEIKDE
HCCCCCCCHHHHCCH
62.8528112733
479MalonylationKEPKEEVKSFMDRKK
CCCHHHHHHHHHHHC
41.0526320211
479UbiquitinationKEPKEEVKSFMDRKK
CCCHHHHHHHHHHHC
41.05-
480PhosphorylationEPKEEVKSFMDRKKG
CCHHHHHHHHHHHCC
30.8628857561
493PhosphorylationKGFTEVKSQNGEFMT
CCCEEEECCCCCEEE
33.7728348404
500PhosphorylationSQNGEFMTHKLKHTE
CCCCCEEEEECCCCC
22.6019664995
502MalonylationNGEFMTHKLKHTENT
CCCEEEEECCCCCCC
50.4926320211
5042-HydroxyisobutyrylationEFMTHKLKHTENTFS
CEEEEECCCCCCCCC
53.97-
504AcetylationEFMTHKLKHTENTFS
CEEEEECCCCCCCCC
53.9727452117
506PhosphorylationMTHKLKHTENTFSRP
EEEECCCCCCCCCCC
29.3723403867
509PhosphorylationKLKHTENTFSRPGGR
ECCCCCCCCCCCCCC
19.4323403867
511PhosphorylationKHTENTFSRPGGRAS
CCCCCCCCCCCCCCC
35.2127134283
518O-linked_GlycosylationSRPGGRASVDTKEAE
CCCCCCCCCCCCCCC
21.1130379171
518PhosphorylationSRPGGRASVDTKEAE
CCCCCCCCCCCCCCC
21.1125159151
521PhosphorylationGGRASVDTKEAEGAP
CCCCCCCCCCCCCCC
28.7323403867
522MalonylationGRASVDTKEAEGAPQ
CCCCCCCCCCCCCCC
50.9226320211
534AcetylationAPQVEAGKRLEELRR
CCCHHHHHHHHHHHH
61.947610153
546PhosphorylationLRRRRGETESEEFEK
HHHHHCCCCHHHHHH
47.8629255136
548PhosphorylationRRRGETESEEFEKLK
HHHCCCCHHHHHHHH
50.2525850435
553AcetylationTESEEFEKLKQKQQE
CCHHHHHHHHHHHHH
67.3226051181
553MalonylationTESEEFEKLKQKQQE
CCHHHHHHHHHHHHH
67.3226320211
569AcetylationALELEELKKKREERR
HHHHHHHHHHHHHHH
60.5726051181
569UbiquitinationALELEELKKKREERR
HHHHHHHHHHHHHHH
60.57-
605MalonylationEEEKRRLKEEIERRR
HHHHHHHHHHHHHHH
52.0326320211
622SulfoxidationAAEKRQKMPEDGLSD
HHHHHHHCCCCCCCC
3.1228183972
628PhosphorylationKMPEDGLSDDKKPFK
HCCCCCCCCCCCCCC
49.6629255136
6312-HydroxyisobutyrylationEDGLSDDKKPFKCFT
CCCCCCCCCCCCCCC
68.30-
631MalonylationEDGLSDDKKPFKCFT
CCCCCCCCCCCCCCC
68.3026320211
632AcetylationDGLSDDKKPFKCFTP
CCCCCCCCCCCCCCC
63.7826051181
632MalonylationDGLSDDKKPFKCFTP
CCCCCCCCCCCCCCC
63.7826320211
638PhosphorylationKKPFKCFTPKGSSLK
CCCCCCCCCCCCCCC
33.2929214152
640AcetylationPFKCFTPKGSSLKIE
CCCCCCCCCCCCCHH
69.2620167786
642PhosphorylationKCFTPKGSSLKIEER
CCCCCCCCCCCHHHH
38.3323403867
643PhosphorylationCFTPKGSSLKIEERA
CCCCCCCCCCHHHHH
42.2123911959
645SumoylationTPKGSSLKIEERAEF
CCCCCCCCHHHHHHH
50.44-
645AcetylationTPKGSSLKIEERAEF
CCCCCCCCHHHHHHH
50.4420167786
645SumoylationTPKGSSLKIEERAEF
CCCCCCCCHHHHHHH
50.4428112733
6552-HydroxyisobutyrylationERAEFLNKSVQKSSG
HHHHHHHHHHHHHCC
54.90-
655AcetylationERAEFLNKSVQKSSG
HHHHHHHHHHHHHCC
54.9026051181
655MalonylationERAEFLNKSVQKSSG
HHHHHHHHHHHHHCC
54.9026320211
655UbiquitinationERAEFLNKSVQKSSG
HHHHHHHHHHHHHCC
54.90-
656PhosphorylationRAEFLNKSVQKSSGV
HHHHHHHHHHHHCCC
28.8023927012
660PhosphorylationLNKSVQKSSGVKSTH
HHHHHHHHCCCCCHH
18.4226462736
661PhosphorylationNKSVQKSSGVKSTHQ
HHHHHHHCCCCCHHH
55.4222617229
665PhosphorylationQKSSGVKSTHQAAIV
HHHCCCCCHHHHHHH
28.8124275569
666PhosphorylationKSSGVKSTHQAAIVS
HHCCCCCHHHHHHHH
16.5828857561
673PhosphorylationTHQAAIVSKIDSRLE
HHHHHHHHHHHHHHH
20.1323911959
674UbiquitinationHQAAIVSKIDSRLEQ
HHHHHHHHHHHHHHH
39.37-
677PhosphorylationAIVSKIDSRLEQYTS
HHHHHHHHHHHHHHH
42.0928857561
682PhosphorylationIDSRLEQYTSAIEGT
HHHHHHHHHHHHCCC
8.0325159151
683PhosphorylationDSRLEQYTSAIEGTK
HHHHHHHHHHHCCCC
16.0426356563
684PhosphorylationSRLEQYTSAIEGTKS
HHHHHHHHHHCCCCC
23.4721712546
689PhosphorylationYTSAIEGTKSAKPTK
HHHHHCCCCCCCCCC
14.7226356563
690UbiquitinationTSAIEGTKSAKPTKP
HHHHCCCCCCCCCCC
60.31-
691O-linked_GlycosylationSAIEGTKSAKPTKPA
HHHCCCCCCCCCCCC
41.17OGP
691PhosphorylationSAIEGTKSAKPTKPA
HHHCCCCCCCCCCCC
41.1726055452
693AcetylationIEGTKSAKPTKPAAS
HCCCCCCCCCCCCHH
61.3826051181
693MalonylationIEGTKSAKPTKPAAS
HCCCCCCCCCCCCHH
61.3826320211
695PhosphorylationGTKSAKPTKPAASDL
CCCCCCCCCCCHHCC
49.2928857561
696MalonylationTKSAKPTKPAASDLP
CCCCCCCCCCHHCCC
40.9826320211
700O-linked_GlycosylationKPTKPAASDLPVPAE
CCCCCCHHCCCCCHH
41.61OGP
700PhosphorylationKPTKPAASDLPVPAE
CCCCCCHHCCCCCHH
41.6128857561
713UbiquitinationAEGVRNIKSMWEKGN
HHHHCCHHHHHHHCC
37.49-
714PhosphorylationEGVRNIKSMWEKGNV
HHHCCHHHHHHHCCC
25.9028857561
718AcetylationNIKSMWEKGNVFSSP
CHHHHHHHCCCCCCC
40.0326051181
718UbiquitinationNIKSMWEKGNVFSSP
CHHHHHHHCCCCCCC
40.03-
723PhosphorylationWEKGNVFSSPTAAGT
HHHCCCCCCCCCCCC
31.0025463755
724PhosphorylationEKGNVFSSPTAAGTP
HHCCCCCCCCCCCCC
18.1429255136
726PhosphorylationGNVFSSPTAAGTPNK
CCCCCCCCCCCCCCC
30.9619664994
730PhosphorylationSSPTAAGTPNKETAG
CCCCCCCCCCCCCCC
20.9729255136
733AcetylationTAAGTPNKETAGLKV
CCCCCCCCCCCCCEE
58.6126051181
733MalonylationTAAGTPNKETAGLKV
CCCCCCCCCCCCCEE
58.6126320211
733UbiquitinationTAAGTPNKETAGLKV
CCCCCCCCCCCCCEE
58.61-
735PhosphorylationAGTPNKETAGLKVGV
CCCCCCCCCCCEEEC
27.8625463755
743PhosphorylationAGLKVGVSSRINEWL
CCCEEECHHHHHHHH
14.1529514088
744PhosphorylationGLKVGVSSRINEWLT
CCEEECHHHHHHHHH
34.4729514088
751PhosphorylationSRINEWLTKTPDGNK
HHHHHHHHCCCCCCC
33.6722167270
752AcetylationRINEWLTKTPDGNKS
HHHHHHHCCCCCCCC
56.7618603641
752MalonylationRINEWLTKTPDGNKS
HHHHHHHCCCCCCCC
56.7626320211
753PhosphorylationINEWLTKTPDGNKSP
HHHHHHCCCCCCCCC
22.7522167270
758AcetylationTKTPDGNKSPAPKPS
HCCCCCCCCCCCCCC
64.4418603663
759PhosphorylationKTPDGNKSPAPKPSD
CCCCCCCCCCCCCCC
30.2322167270
763MalonylationGNKSPAPKPSDLRPG
CCCCCCCCCCCCCCC
60.3026320211
765PhosphorylationKSPAPKPSDLRPGDV
CCCCCCCCCCCCCCC
56.2420201521
773PhosphorylationDLRPGDVSSKRNLWE
CCCCCCCCCCCCCCH
34.5823927012
774PhosphorylationLRPGDVSSKRNLWEK
CCCCCCCCCCCCCHH
35.1723403867
7752-HydroxyisobutyrylationRPGDVSSKRNLWEKQ
CCCCCCCCCCCCHHC
37.49-
775MethylationRPGDVSSKRNLWEKQ
CCCCCCCCCCCCHHC
37.49-
775UbiquitinationRPGDVSSKRNLWEKQ
CCCCCCCCCCCCHHC
37.49-
783PhosphorylationRNLWEKQSVDKVTSP
CCCCHHCCCCCCCCC
43.2723927012
786MalonylationWEKQSVDKVTSPTKV
CHHCCCCCCCCCCCC
45.3026320211
788PhosphorylationKQSVDKVTSPTKV--
HCCCCCCCCCCCC--
34.4325463755
789PhosphorylationQSVDKVTSPTKV---
CCCCCCCCCCCC---
33.2922167270
791PhosphorylationVDKVTSPTKV-----
CCCCCCCCCC-----
44.1830266825
7922-HydroxyisobutyrylationDKVTSPTKV------
CCCCCCCCC------
49.70-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
534SPhosphorylationKinaseMAPK1P28482
GPS
534SPhosphorylationKinaseMAPK3P27361
GPS
714SPhosphorylationKinasePAK2Q13177
PSP
730TPhosphorylationKinaseCDK2P24941
PSP
744SPhosphorylationKinasePAK2Q13177
PSP
759SPhosphorylationKinaseMAPK3P27361
GPS
789SPhosphorylationKinaseMAPK1P63085
GPS
789SPhosphorylationKinaseMAPK3P27361
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CALD1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CALD1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CSK21_HUMANCSNK2A1physical
22863883

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CALD1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-724; THR-726 ANDTHR-730, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-656; SER-724; THR-730;THR-735; THR-753; SER-759 AND SER-789, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518; SER-759 ANDSER-765, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-656; SER-723; SER-724AND THR-730, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-27; SER-202; SER-724;THR-730 AND SER-759, AND MASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-682, AND MASSSPECTROMETRY.

TOP